MoneyWorks4Me

Bajaj Healthcare - Quaterly Results

02 Nov 2021 Evaluate
The sales slipped to Rs. 1509.12 millions for the September 2021 quarter as against Rs. 2066.35 millions during the year-ago period.The Net Profit of the company registered a slight decline of -14.24% to Rs. 172.52  millions from Rs. 201.16 millions.Operating Profit reported a sharp decline to 290.84 millions from 344.03 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 1509.12 2066.35 -26.97 3366.01 3464.68 -2.85 6569.84 4100.08 60.24
Other Income 1.18 20.95 -94.37 7.97 29.97 -73.41 69.13 31.79 117.46
PBIDT 290.84 344.03 -15.46 632.62 606.51 4.30 1432.39 546.33 162.18
Interest 25.00 21.72 15.10 52.93 42.20 25.43 82.96 64.49 28.64
PBDT 265.84 322.31 -17.52 579.69 564.31 2.73 1349.43 481.84 180.06
Depreciation 44.07 39.75 10.87 85.38 77.40 10.31 161.24 121.23 33.00
PBT 221.77 282.56 -21.51 494.31 486.91 1.52 1188.19 360.61 229.49
TAX 49.25 81.40 -39.50 129.61 132.83 -2.42 357.11 108.24 229.92
Deferred Tax 3.64 -1.26 -388.89 2.61 -7.17 -136.40 4.99 14.89 -66.49
PAT 172.52 201.16 -14.24 364.70 354.08 3.00 831.08 252.37 229.31
Equity 137.99 137.99 0.00 137.99 137.99 0.00 137.99 137.99 0.00
PBIDTM(%) 19.27 16.65 15.75 18.79 17.51 7.36 21.80 13.32 63.62
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..